pSivida Corp. Company Profile (NASDAQ:PSDV)

About pSivida Corp.

pSivida Corp. logopSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PSDV
  • CUSIP:
Key Metrics:
  • Previous Close: $1.75
  • 50 Day Moving Average: $1.81
  • 200 Day Moving Average: $2.43
  • 52-Week Range: $1.50 - $4.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.09
  • P/E Growth: 0.00
  • Market Cap: $60.83M
  • Outstanding Shares: 34,176,000
  • Beta: 1.74
Profitability:
  • Net Margins: -271.33%
  • Return on Equity: -97.39%
  • Return on Assets: -66.37%
Debt:
  • Current Ratio: 3.77%
  • Quick Ratio: 3.77%
Additional Links:
Companies Related to pSivida Corp.:

Analyst Ratings

Consensus Ratings for pSivida Corp. (NASDAQ:PSDV) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00 (293.26% upside)

Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)
Show:
DateFirmActionRatingPrice TargetDetails
12/6/2016FBR & CoReiterated RatingOutperform$7.00View Rating Details
12/29/2015Ladenburg Thalmann Financial ServicesReiterated RatingBuyView Rating Details
12/17/2015Northland SecuritiesReiterated RatingBuyView Rating Details
7/7/2015MLV & Co.Reiterated RatingBuy$6.50View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for pSivida Corp. (NASDAQ:PSDV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017        
11/7/2016Q1($0.19)($0.21)ViewListenView Earnings Details
9/12/2016Q4($0.13)($0.19)ViewListenView Earnings Details
5/5/2016Q3($0.20)($0.15)ViewN/AView Earnings Details
11/5/2015Q116($0.15)($0.17)ViewN/AView Earnings Details
9/9/2015Q415($0.14)($0.17)$409.00 millionViewN/AView Earnings Details
5/8/2015Q315($0.13)($0.17)ViewN/AView Earnings Details
2/5/2015($0.13)($0.14)ViewN/AView Earnings Details
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details
9/9/2014Q414($0.15)($0.15)ViewN/AView Earnings Details
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details
11/12/2013Q1($0.14)ViewListenView Earnings Details
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
Current Year EPS Consensus Estimate: $-0.52 EPS
Next Year EPS Consensus Estimate: $-0.22 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.10)($0.10)($0.10)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for pSivida Corp. (NASDAQ:PSDV)
Insider Ownership Percentage: 4.49%
Institutional Ownership Percentage: 29.03%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for pSivida Corp. (NASDAQ:PSDV)
DateHeadline
News IconStock Watch: Examining the Levels on Shares of pSivida Corp. (NASDAQ:PSDV) - Baldwin Journal (NASDAQ:PSDV)
baldwinjournal.com - February 24 at 8:36 PM
News IconAre Analysts Optimistic About Where pSivida Corp. (NASDAQ:PSDV) is Heading? - Winfield Review (NASDAQ:PSDV)
winfieldreview.com - February 24 at 8:36 PM
News IconWhat are Research Firms Saying About pSivida Corp. (NASDAQ:PSDV)? - Aiken Advocate (NASDAQ:PSDV)
aikenadvocate.com - February 23 at 7:28 PM
News IconpSivida Corp PSDV Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:PSDV)
www.bioportfolio.com - February 18 at 8:03 AM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:PSDV)
seekingalpha.com - February 16 at 6:57 PM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow (NASDAQ:PSDV)
seekingalpha.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials (NASDAQ:PSDV)
finance.yahoo.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials (NASDAQ:PSDV)
finance.yahoo.com - February 16 at 6:57 PM
News IconSeasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development - Satellite PR News (press release) (NASDAQ:PSDV)
www.satprnews.com - February 12 at 7:13 PM
globenewswire.com logopSivida to Present at the 2017 BIO CEO & Investor Conference - GlobeNewswire (press release) (NASDAQ:PSDV)
globenewswire.com - February 11 at 2:32 AM
News IconMarket Rover: Looking at Levels on Shares of pSivida Corp. (PSDV) - Davidson Register (NASDAQ:PSDV)
davidsonregister.com - February 10 at 9:30 PM
finance.yahoo.com logopSivida to Present at the 2017 BIO CEO & Investor Conference (NASDAQ:PSDV)
finance.yahoo.com - February 10 at 9:30 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 10-Q, Quarterly Report (NASDAQ:PSDV)
biz.yahoo.com - February 9 at 10:02 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:PSDV)
us.rd.yahoo.com - February 9 at 2:15 AM
globenewswire.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results - GlobeNewswire (press release) (NASDAQ:PSDV)
www.globenewswire.com - February 8 at 9:12 PM
News IconpSivida Corp. (NASDAQ:PSDV) moves down at least -2.71% on its earnings reaction day - Post Analyst (NASDAQ:PSDV)
postanalyst.com - February 8 at 9:12 PM
News IconTechnical Toolbox: Investor Focus on pSivida Corp. (PSDV) - Piedmont Register (NASDAQ:PSDV)
piedmontregister.com - February 8 at 9:12 PM
finance.yahoo.com logoEdited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT (NASDAQ:PSDV)
finance.yahoo.com - February 8 at 9:12 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:PSDV)
biz.yahoo.com - February 8 at 9:12 PM
us.rd.yahoo.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results (NASDAQ:PSDV)
us.rd.yahoo.com - February 7 at 9:59 PM
sg.finance.yahoo.com logoPSivida posts 2Q loss (NASDAQ:PSDV)
sg.finance.yahoo.com - February 7 at 9:59 PM
biz.yahoo.com logoQ2 2017 pSivida Corp Earnings Release - After Market Close (NASDAQ:PSDV)
biz.yahoo.com - February 7 at 8:43 AM
News IconStock Dragging Lower Heading Into The Open: pSivida Corp. (NASDAQ:PSDV) - Aiken Advocate (NASDAQ:PSDV)
aikenadvocate.com - February 2 at 3:05 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at pSivida Corp. (NASDAQ:PSDV) - Nelson Research (NASDAQ:PSDV)
nelsonobserver.com - February 1 at 10:04 PM
News IconADX in View on Shares of pSivida Corp. (PSDV) - Sherwood Daily (NASDAQ:PSDV)
sherwooddaily.com - February 1 at 10:04 PM
News IconCan This Stock Pick Up Any Momentum: pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - February 1 at 10:04 PM
News IconBargain Hunter's Delight: What's the Latest on pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 30 at 8:01 PM
News IconEarnings in Full Force, Analysts Take Aim at pSivida Corp. (NASDAQ:PSDV) - Wall Street Beacon (NASDAQ:PSDV)
wsbeacon.com - January 29 at 8:41 AM
News IconpSivida, Corp. (NASDAQ:PSDV) Announces Release Date and Conference Call Information for First Quarter Fiscal ... - Nelson Observer (NASDAQ:PSDV)
nelsonobserver.com - January 29 at 8:41 AM
feeds.benzinga.com logopSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information (NASDAQ:PSDV)
feeds.benzinga.com - January 25 at 8:49 AM
News IconMarket Scope: F-Score and Volatility Review for pSivida Corp. (NASDAQ:PSDV) - The Tribune (NASDAQ:PSDV)
lakecitytribune.com - January 24 at 8:09 PM
News IconEquity Rundown: RSI and CCI Check on pSivida Corp. (PSDV) - Sherwood Daily (NASDAQ:PSDV)
sherwooddaily.com - January 24 at 8:09 PM
News IconBoom or Bust? Is there any value in pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 24 at 8:30 AM
News IconUpside Alert: Delving into Shares of pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 24 at 8:30 AM
News IconBrokers Add To Their Ratings On PSivida Corp. (PSDV) - NewsDen (NASDAQ:PSDV)
newsden.net - January 22 at 12:08 AM
News IconWatching the Technicals on Shares of pSivida Corp. (PSDV) - Sherwood Daily (NASDAQ:PSDV)
sherwooddaily.com - January 21 at 1:15 AM
News IconIs There a Catalyst Out There For pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 21 at 1:15 AM
News IconRipe for A Big Move? Update on pSivida Corp. (NASDAQ:PSDV ... - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 21 at 1:15 AM
News IconPumping the Brakes as Stock Dragged Lower Mid-Session: pSivida Corp. (NASDAQ:PSDV) - Wall Street Beacon (NASDAQ:PSDV)
wsbeacon.com - January 19 at 5:58 AM
News IconCan This Stock Make a Ripple in the Market: pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 19 at 5:58 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on pSivida Corp. (NASDAQ:PSDV) - Wall Street Beacon (NASDAQ:PSDV)
wsbeacon.com - January 19 at 5:58 AM
News IconShooting From the Hip, Stock Reaches Most Volatile List: pSivida Corp. (NASDAQ:PSDV) - Wall Street Beacon (NASDAQ:PSDV)
wsbeacon.com - January 19 at 5:58 AM
News IconActive Trading Watch on Shares of pSivida Corp. (PSDV) - Sherwood Daily (NASDAQ:PSDV)
sherwooddaily.com - January 17 at 7:43 PM
News IconStock Update on Earnings & Estimates for pSivida Corp. (NASDAQ:PSDV) - Aiken Advocate (NASDAQ:PSDV)
aikenadvocate.com - January 17 at 7:43 PM
News IconPSivida Corp. (PSDV) – Latest Broker Consensus - NewsDen (NASDAQ:PSDV)
newsden.net - January 17 at 7:43 PM
News IconUnder the Microscope We Place Shares of pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 17 at 7:43 PM
News IconpSivida Corp PSDV Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:PSDV)
www.bioportfolio.com - January 16 at 7:49 PM
News IconCalling all Bargain Hunters: Stock Update on pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 16 at 11:56 AM
News IconIs This Equity Ready for a Breakout: pSivida Corp. (NASDAQ:PSDV) - Prospect Journal (NASDAQ:PSDV)
prospectjournal.com - January 13 at 8:00 AM
News IconWill The Needle Move For pSivida Corp. (NASDAQ:PSDV) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:PSDV)
wsbeacon.com - January 13 at 8:00 AM

Social

What is pSivida Corp.'s stock symbol?

pSivida Corp. trades on the NASDAQ under the ticker symbol "PSDV."

Where is pSivida Corp.'s stock going? Where will pSivida Corp.'s stock price be in 2017?

1 analysts have issued 12-month price targets for pSivida Corp.'s stock. Their forecasts range from $7.00 to $7.00. On average, they expect pSivida Corp.'s stock price to reach $7.00 in the next year.

When will pSivida Corp. announce their earnings?

pSivida Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

Who owns pSivida Corp. stock?

pSivida Corp.'s stock is owned by a variety of of institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (6.67%), Deerfield Management Co. (4.37%), Renaissance Technologies LLC (2.65%), North Run Capital LP (2.63%) and Bard Associates Inc. (0.30%). Company insiders that own pSivida Corp. stock include Leonard S Ross and Paul Ashton.

Who sold pSivida Corp. stock? Who is selling pSivida Corp. stock?

pSivida Corp.'s stock was sold by a variety of institutional investors in the last quarter, including North Run Capital LP and Bard Associates Inc..

Who bought pSivida Corp. stock? Who is buying pSivida Corp. stock?

pSivida Corp.'s stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC and Renaissance Technologies LLC.

How do I buy pSivida Corp. stock?

Shares of pSivida Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of pSivida Corp. stock cost?

One share of pSivida Corp. stock can currently be purchased for approximately $1.78.

pSivida Corp. (NASDAQ:PSDV) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for pSivida Corp. (NASDAQ:PSDV)

Earnings History Chart

Earnings by Quarter for pSivida Corp. (NASDAQ:PSDV)

Dividend History Chart

Dividend Payments by Quarter for pSivida Corp. (NASDAQ:PSDV)

Last Updated on 2/25/2017 by MarketBeat.com Staff